Hereditary Transthyretin-mediated (ATTRv) Amyloidosis
1 clinical trials · Condition
◉ Watch Hereditary Transthyretin-mediated (ATTRv) Amyloidosis
| Record | Firm | Date |
|---|---|---|
| A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation (NCT04201418) | Alnylam Pharmaceuticals | 2019-12-18 |
Track Hereditary Transthyretin-mediated (ATTRv) Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.